Active Ingredient History
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Color Vision Defects (Phase 1/Phase 2)
Eye Diseases (Phase 1/Phase 2)
Glaucoma (Phase 2)
Glaucoma, Open-Angle (Phase 1)
Macula Lutea (Phase 2)
Macular Degeneration (Phase 2)
Optic Neuropathy, Ischemic (Phase 1)
Retinitis Pigmentosa (Phase 2)
Telangiectasis (Phase 1)
Usher Syndromes (Phase 2)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
